SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000896264-24-000138
Filing Date
2024-04-30
Accepted
2024-04-30 16:08:14
Documents
17
Period of Report
2024-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K usna-20240430.htm   iXBRL 8-K 28181
2 EX-99.1 q12024earningsreleaseex991.htm EX-99.1 159644
3 EX-99.2 q12024managementcommentary.htm EX-99.2 66202
7 usanacorplogoresized.jpg GRAPHIC 8913
8 usanacorplogoresizedb.jpg GRAPHIC 8913
  Complete submission text file 0000896264-24-000138.txt   425171

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20240430.xsd EX-101.SCH 1895
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20240430_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20240430_pre.xml EX-101.PRE 12504
20 EXTRACTED XBRL INSTANCE DOCUMENT usna-20240430_htm.xml XML 2732
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1230
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 24897209
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)